Search by Drug Name or NDC

    NDC 71610-0503-60 Terazosin 5 mg/1 Details

    Terazosin 5 mg/1

    Terazosin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is TERAZOSIN HYDROCHLORIDE.

    Product Information

    NDC 71610-0503
    Product ID 71610-503_b23a32b3-7e6b-4b58-be96-303ac3ef069a
    Associated GPIs 36202040100115
    GCN Sequence Number 022651
    GCN Sequence Number Description terazosin HCl CAPSULE 5 MG ORAL
    HIC3 J7B
    HIC3 Description ALPHA-ADRENERGIC BLOCKING AGENTS
    GCN 47126
    HICL Sequence Number 000094
    HICL Sequence Number Description TERAZOSIN HCL
    Brand/Generic Generic
    Proprietary Name Terazosin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Terazosin Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name TERAZOSIN HYDROCHLORIDE
    Labeler Name Aphena Pharma Solutions - Tennessee, LLC
    Pharmaceutical Class Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075317
    Listing Certified Through 2024-12-31

    Package

    NDC 71610-0503-60 (71610050360)

    NDC Package Code 71610-503-60
    Billing NDC 71610050360
    Package 90 CAPSULE in 1 BOTTLE (71610-503-60)
    Marketing Start Date 2020-12-08
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 81d5422c-ff57-4f6d-927c-5de4dd7e1169 Details

    Revised: 1/2021